Investor: U.S. Private Equity, U.K. Private Equity, China Private Equity
Invested: July 2017
Prescient is a leading product strategy consultancy to the global biopharmaceutical industry. The business provides decision support services to help its clients make better clinical and commercial decisions resulting in enhanced outcomes for patients, customers and shareholders.